Mangaluru: UTK inaugurates Ahmed Anwar's photo exhibition on Street Life

Mangaluru, Apr 17: Authorities in Dakshina Kannada have announced a fresh coronavirus positive case. The patient is a resident of Uppinangady in Puttur taluk.

With this the total number of covid-19 positive cases in this coastal district mounted to 13 even though most of the patients have recovered and returned home after treatment.

In past twelve days this is the first coronavirus case reported in the district.

It is learnt that the 39-year-old had been to Delhi. He was home quarantined for past few days. His throat swabs were tested positive for the deadly disease today.

Mysuru, Jan 11: City Police has intensified its search for a girl student who a displayed 'Free Kashmir' poster during a protest two days back.

According to police, a girl student displayed the poster carrying an anti-national message, during the protest organised by University of Mysore Researchers Association and other organisation on Wednesday to oppose the attack on the students and the teachers in Jawaharlal Nehru University in the National Capital. An officer said that as per the documents available, it appears that a girl student displayed the placard for a few minutes.

"We are looking for the accused". The Jayalakshmipuram police have taken up suo motu cognisance of the case. Meanwhile. the office of Governor Vajubhai Vala, on Thursday, sought a detailed report from the University of Mysore (UoM) over the incident. The city police have booked the protestors under Section 124A of the Indian Penal Code (IPC).

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.